Review Note
Last Update: 03/27/2025 10:27 PM
Current Deck: ACG Part 2::Obstetrics
New Card (Unpublished)Currently Published Content
Front
Back
No published tags.
Pending Suggestions
Field Change Suggestions:
Front
Commit #309796SS_OB 1.36 Discuss the pathophysiology and anaesthetic management of co-existing maternal conditions as described in the Perioperative medicine Clinical Fundamental, in particular:
∙ Morbid obesityBack
Commit #309796Obesity
-
BMI > 40 = morbid obesity.
-
Associated with reduced life expectancy and increased obstetric and anesthetic-related morbidity.
-
Normal weight gain in pregnancy from baseline: 10-16kg.
Pathophysiology of Morbid Obesity Affecting Pregnancy:
-
A combination of physiological changes associated with pregnancy and obesity results in organ systems nearing their physiological limits.
-
Reduced FRC, RV, and ERV from fat deposition in the chest wall and diaphragm and cephalad movement of the diaphragm associated with pregnancy.
-
FRC may fall below closing capacity, resulting in shunting.
-
Reduced compliance due to increased pulmonary blood volume, reduced FRC, and reduced chest wall compliance. This may be exacerbated by supine, lithotomy, and Trendelenberg positions.
-
Worsening V/Q matching as lung apices are preferentially ventilated, resulting in lower PaO2 (80-85mmHg vs 104-108mmHg in non-obese).
-
Increased work of breathing (WOB) from reduced compliance and chest wall weight.
-
Rapid shallow breathing with relative restrictive respiratory defect.
-
Linear increase in oxygen consumption (VO2) and CO2 production (VCO2).
-
Increased risk of sleep apnoea.
-
Airway: Soft tissue adiposity, capillary engorgement, and mucosal edema.
Cardiovascular:
-
Increase in CO proportional to obesity (30-50ml/100g adipose tissue/min).
-
Increase in blood volume, though the ratio of blood volume to mass is reduced.
-
Hypertension due to increased plasma leptin, insulin, and inflammatory markers (IL-6, CRP, TNFa), leading to LVH or dilation in severe cases, and eventually systolic dysfunction.
-
Diastolic dysfunction from reduced diastolic time (from increased HR), LVH, and fatty infiltration of tissue.
-
Increased risk of arrhythmias from hypertrophy, dilation, fat deposition in the conducting system, IHD, sleep apnea, and increased catecholamines.
-
Cardiomyopathy (obesity is a risk factor), with difficulty diagnosing it via TTE.
Gastrointestinal:
-
Increased reflux risk due to increased IAP, relaxation of LOS, reduced GIT motility, increased acidity, and volume.
Metabolic:
-
Poor glycaemic control from increased HPL, human chorionic gonadotropin, and steroid hormones, which increase resistance of target tissues to insulin.
-
Hyperlipidemia due to insulin secretion.
Renal:
-
Increased ACE and renin levels.
-
Reduced renal blood flow (RBF) from increased IAP.
-
Increased sodium reabsorption from increased leptin.
Endocrine:
-
Increased SNS drive leading to hypertension, sodium and water reabsorption from increased leptin.
Coagulation:
-
Increased risk of DVT and thromboembolic events.
Pregnancy-related Morbidity – Increased Risk of:
-
Fetal congenital malformations (e.g., neural tube defects).
-
Miscarriage and premature delivery.
-
Pre-eclampsia.
-
GDM.
-
LSCS.
-
Wound infection and breakdown.
-
Endometritis.
-
Induction and augmentation of labor.
-
Poor contractility of uterus pre and post delivery due to fatty infiltration.
-
Obstructed labor due to intra-abdominal fat.
-
Shoulder dystocia.
Pharmacokinetics:
-
Increased fat and lean body mass.
-
Reduced total body water (TBW).
Implications for Obstetric Anaesthetic Care:
Labor:
-
LSCS:
-
Pre-op: Early regional analgesia in labor is recommended as:
-
More likely to require emergency operative intervention, and general anesthesia (GA) confers greater risks.
-
Optimal positioning with less pain early in labor.
-
-
Difficult placement due to loss of landmarks and limited back flexion.
-
Epidural is associated with:
-
Higher failure rates.
-
More than 1 attempt.
-
Migration of catheter.
-
Inconsistent spread of epidural solution, with potential for greater cephalad spread due to more epidural fat and venous distension.
-
Higher risk of accidental dural puncture (4% vs 2.5%).
-
Lower risk of PDPH due to increased IAP and epidural space pressure.
-
-
Antacid prophylaxis to reduce risk of reflux and aspiration.
-
Intra-op:
-
Neuraxial anesthesia is preferred.
-
CSE is recommended as:
-
Spinal dose and height of block are difficult to predict.
-
Surgery may be prolonged due to operative difficulty.
-
Long spinal and epidural needles need to be available.
-
-
Airway:
-
Higher risk of failure to intubate (1:250).
-
Difficult BMV due to reduced chest wall compliance and increased IAP.
-
Rapid desaturation from reduced FRC and increased O2 consumption.
-
Adequate pre-oxygenation is essential.
-
Appropriate positioning with head up or ramped, allowing breasts to fall toward axillae to laryngoscopy and reduce pressure on chest wall.
-
Range of difficult intubation equipment should be available.
-
-
Breathing:
-
Ventilation may be difficult, leading to barotrauma and volutrauma.
-
Head up positioning may improve respiratory compliance.
-
PEEP can aid oxygenation.
-
Drug Dosage Adjustment:
-
Thiopentone and propofol doses – based on LBM/IBW.
-
NDMR – based on IBW to avoid unwanted prolonged blockade and residual neuromuscular blockade.
-
Suxamethonium – use TBW for dosing (offset is quick due to increased activity of pseudocholinesterase in obesity).
Other (Positioning/Equipment):
-
Adequate and trained theater assistants and staff to facilitate transfer and prevent injury to both staff and patient.
-
Bariatric hover mattress.
-
Wide BP cuffs to provide accurate readings (small cuffs may result in falsely high readings).
-
Large compression stockings and calf compression.
-
Adequate left tilt to avoid aorto-caval compression may be tricky.
Post-op:
-
Airway: Preferable to extubate awake in sitting position to optimize ventilation.
-
Analgesia: Adequate, regular, and multi-modal analgesia and encourage mobilization.
-
Destination: May need transfer to HDU for appropriate monitoring and CPAP.
-
Reduce risk of pulmonary complications (e.g., hypoxemia, atelectasis, pneumonia, pulmonary edema).
-
Reduce risk of thromboembolic events with thrombophylaxis, TEDS, and SCUDS.